NRC Health Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
NRC Health (NRC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $33.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-05
- NRC Health effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2017-09-30 was $384.00K.
- NRC Health effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $33.00K, a 70.80% decline from fiscal 2024.
- NRC Health effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $113.00K, a 22.83% increase from fiscal 2023.
- NRC Health effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $92.00K, a 206.67% increase from fiscal 2022.
- NRC Health effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $30.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|---|---|
| 2025-12-31 | $33.00K 10-K · filed 2026-03-05 | ||
| 2024-12-31 | $113.00K 10-K · filed 2026-03-05 | ||
| 2023-12-31 | $92.00K 10-K · filed 2026-03-05 | ||
| 2022-12-31 | $30.00K 10-K · filed 2025-03-17 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | ||
| 2017-09-30 | $384.00K 10-Q · filed 2017-11-09 | $384.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |